TY  - GEN 
AU  - Martín Molina, Francisco
PY  - 2022
UR  - https://hdl.handle.net/10481/79763
AB  - Adoptive Cell Therapy (ACT) to treat cancer represents a rapidly evolving field. New
approaches for the genetic engineering of immune effector cells with either a T cell
receptor (TCR) or a chimeric antigen receptor (CAR) (Figure 1 Panels A and...
LA  - eng
PB  - Frontiers
KW  - Adoptive cell theraphy
KW  - CAR-T cells
KW  - TCR-engineered T cells
KW  - Tumor antigens
KW  - Mechanisms of resistance
TI  - Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
DO  - 10.3389/fimmu.2022.1119363
ER  -